CR-001 (crescent biopharma)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameCR-001 (crescent biopharma)
Drug Alias NamePR-054CR-001SKB118SKB-118
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockersVascular endothelial growth factor inhibitors
TargetsProgrammed cell death protein 1Vascular endothelial growth factor
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesParagon Therapeutics IncCrescent Biopharma Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCrescent Biopharma IncSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Inactive CompaniesParagon Therapeutics Inc
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A